Market Insight The orphan pharmaceuticals market was valued at USD 160.78 billion in 2021 and is expected to rise from USD 175.57 billion in 2022 to USD 355.00 billion by 2030, representing a compound annual growth rate (CAGR) of 9.20% during the forecast period (2022- 2030). The Orphan Drugs Market is experiencing notable growth, with increasing focus on orphan medicines for rare diseases....